. Janvier, Consultable en ligne à01016- 20140116ARTFIG00700-ivg-l-amendement-qui-fait-polemique.php (29) Statistiques d'état civil sur les naissances en 2011, Institut National de la Statistique et des Etudes Economiques (Insee) consulté le 10 avril 2014 (en ligne) disponible à l'url) Statistiques annuelles des établissements de santé 2012 cité dans le Rapport relatif à l'accès à l'IVG Volet 2 : Accès à l'IVG dans les territoires, 2014.

=. Mifépristone and . Ru, CRAT) (Consulté le 29 mars 2014) Consultable en ligne à L'URL : http://www.lecrat.org/articleSearchSaisie.php3 (33) Rapport public d'évaluation « Mifégyne 200 mg, comprimé (Mifépristone) » Afssaps Septembre (34) Fialaa C. Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue, Contraception, vol.74, pp.66-86, 2006.

C. Mckinley, K. Thong, and D. Baird, Pregnancy: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol, Human Reproduction, vol.8, issue.9, pp.1502-1507, 1993.
DOI : 10.1093/oxfordjournals.humrep.a138287

P. Ashok, G. Penney, G. Flett, and A. Templeton, An effective regimen for early medical abortion: a report of 2000 consecutive cases, Human Reproduction, vol.13, issue.10, pp.2962-2967, 1998.
DOI : 10.1093/humrep/13.10.2962

E. Schaff, S. Fielding, S. Eisinger, L. Stadalius, and L. Fuller, Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days, Contraception, vol.61, issue.1, pp.41-47, 2000.
DOI : 10.1016/S0010-7824(99)00119-5

C. Shannon, B. Winikoff, R. Hausknecht, E. Schaff, P. Blumenthal et al., Multicenter trial of a simplified mifepristone medical abortion regimen

P. Goldstone, J. Michelson, and E. Williamson, Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study, The Medical Journal of Australia, vol.197, issue.5, pp.282-286, 2012.
DOI : 10.5694/mja12.10297

M. Lievre and R. Sitruk-ware, Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy, Contraception, vol.80, issue.1, pp.95-100, 2009.
DOI : 10.1016/j.contraception.2009.01.011

R. Kulier, A. Gülmezoglu, G. Hofmeyr, L. Cheng, and A. Campana, Medical methods for rst trimester abortion (Review), Cochrane Database Syst Rev, issue.42 2, 2004.

O. Tang, H. Schweer, H. Seyberth, S. Lee, and P. Ho, Pharmacokinetics of different routes of administration of misoprostol, Human Reproduction, vol.17, issue.2, pp.332-338, 2002.
DOI : 10.1093/humrep/17.2.332

M. Fischer, J. Bhatnagar, J. Guarner, S. Reagan, J. Hacker et al., after Medical Abortion, New England Journal of Medicine, vol.353, issue.22, pp.2352-60, 2005.
DOI : 10.1056/NEJMoa051620

H. Hamoda, P. Ashok, J. Dow, G. Flett, and A. Templeton, A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation, Contraception, vol.68, issue.5, pp.335-343, 2003.
DOI : 10.1016/j.contraception.2003.07.004

B. Winikoff, I. Dzuba, M. Creinin, W. Crowden, A. Goldberg et al., Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion, Obstetrics & Gynecology, vol.112, issue.6, pp.1303-1313, 2008.
DOI : 10.1097/AOG.0b013e31818d8eb4

S. Raghavan, R. Comendant, I. Digol, S. Ungureanu, V. Friptu et al., Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol, Contraception, vol.79, issue.2, pp.84-90, 2009.
DOI : 10.1016/j.contraception.2008.09.001

M. Fjerstad, I. Sivin, E. Lichtenberg, J. Trussell, C. K. Cullins et al., Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days, Contraception, vol.80, issue.3, pp.282-288, 2009.
DOI : 10.1016/j.contraception.2009.03.010

H. Von, N. Huong, G. Piaggio, M. Bayalag, E. Cabezas et al., Misoprostol dose and route after mifepristone for early medical abortion: a randomized controlled noninferiority trial, BJOG, vol.117, issue.5110, pp.1186-96, 2010.

P. Faucher, D. Hassoun, C. Shannon, E. Wiebe, F. Jacot et al., Interruption volontaire de grossesse médicamenteuse De Boeck EstemRegimens of misoprostol with mifepristone for early medical abortion: a randomized trial, Octobre. BJOG, vol.113, issue.526, pp.16-53, 2006.

K. Coyaji, U. Krishna, S. Ambardekar, H. Bracken, V. Raote et al., Are two doses of misoprostol after mifepristone for early abortion better than one?, BJOG: An International Journal of Obstetrics & Gynaecology, vol.284, issue.3, pp.271-278, 2007.
DOI : 10.1111/j.1471-0528.2006.01208.x

M. Jensen, J. Turner, and J. Romano, What is the maximum number of levels needed in pain intensity measurement?, Pain, vol.58, issue.3, pp.387-92, 1994.
DOI : 10.1016/0304-3959(94)90133-3

M. Jensen, L. Turner, J. Turner, and J. Romano, The use of multiple-item scales for pain intensity measurement in chronic pain patients, Pain, vol.67, issue.1, pp.35-40, 1996.
DOI : 10.1016/0304-3959(96)03078-3

M. Jensen and K. P. , Self-report scales and procedures for assessing pain in adults Handbook of pain assessment, pp.135-51, 1992.

A. Coutaux, Douleur et son traitement chez l'adulte EMC Traité de médecine Akos, pp.5-1180, 2011.
DOI : 10.1016/s1634-6939(11)52323-3

B. Sallerin, . Les, and . Pharmacologie, Consulté le 18 avril 2014) disponible à l'url : http://www.medecine.upstlse .fr/du_diu/fichiers/sallerin/antalgiques.pdf (87) Organisation Mondiale de la Santé

C. Fiala and K. Gemzell-danielsson, Review of medical abortion using mifepristone in combination with a prostaglandin analogue, Contraception, vol.74, issue.1, pp.66-86, 2006.
DOI : 10.1016/j.contraception.2006.03.018

S. Avraham, I. Gat, N. Duvdevani, J. Haas, Y. Frenkel et al., Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study, Fertility and Sterility, vol.97, issue.3, pp.612-617, 2012.
DOI : 10.1016/j.fertnstert.2011.12.041

E. Raymond, M. Weaver, K. Louie, G. Dean, L. Porsch et al., Prophylactic Compared With Therapeutic Ibuprofen Analgesia in First-Trimester Medical Abortion, Obstetrics & Gynecology, vol.122, issue.3, pp.558-64, 2013.
DOI : 10.1097/AOG.0b013e31829d5a33

C. Moreau, J. Trussell, J. Desfreres, and N. Bajos, Medical vs. surgical abortion: the importance of women's choice, Contraception, vol.84, issue.3, pp.224-233, 2011.
DOI : 10.1016/j.contraception.2011.01.011

L. Article, 2212-3 du Code de la Santé publique (122) Statistiques Annuelles des Etablissements de santé (SAE) cité dans le Rapport relatif à l'accès à l'IVG Volet 2 : Accès à l

C. Soulat and M. Gelly, Immediate complications of surgical abortion